Lipid levels and insulin resistance markers in patients with colorectal cancer: Propensity score matching analysis

Figures

• 

  Figure 1. Flow of included participants. CRC: Colorectal cancer; PSM: Propensity score matching.

• 

  Figure 2. Serum lipid, triglyceride-glucose index, and atherosclerotic index in patients with colorectal cancer and healthy participants. A: Serum lipids including total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C); B: Triglyceride-glucose (TyG) index and atherosclerotic index (AI) in all research subjects; C: Serum lipids; D: TyG index and AI in male subjects; E and F: Serum lipids; TyG index, and AI in female subjects. Data are presented as the mean ± standard deviation and analyzed by the Student’s t-test. aP < 0.05; bP < 0.01; cP < 0.001. CRC: Colorectal cancer.

• 

  Figure 3. Serum lipid, triglyceride-glucose index, and atherosclerotic index in patients with colorectal cancer and healthy participants after propensity score matching. A and B: Serum lipids, triglyceride-glucose (TyG) index and atherosclerotic index (AI) in all research subjects after propensity score matching (PSM); C and D: Serum lipids, TyG index, and AI in male subjects after PSM; E and F: Serum lipids, TyG index, and AI in female subjects after PSM. Data are presented as the mean ± standard deviation and analyzed by the Student’s t-test. aP < 0.05; bP < 0.01; cP < 0.001. CRC: Colorectal cancer; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; TC: Total cholesterol; TG: Triglyceride.

• 

  Figure 4. Relationships between serum lipid levels and the malignancy and invasiveness of colorectal cancer. A and B: Serum lipids, triglyceride-glucose (TyG) index, and atherosclerotic index (AI) in different tumor stage of colorectal cancer (CRC); C and D: Serum lipids, TyG index, and AI in patients with CRC with or without with lymph node metastasis; E and F: Serum lipids, TyG index, and AI in patients with CRC with different differentiations. Data are presented as the mean ± standard deviation and analyzed by the Student’s t-test. aP < 0.05; bP < 0.01; cP < 0.001. HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; TC: Total cholesterol; TG: Triglyceride.

• 

  Figure 5. Relationships between serum lipid levels and tumor location. A and B: Serum lipids, triglyceride-glucose (TyG) index, and atherosclerotic index (AI) in patients with colorectal cancer (CRC) and rectal cancer; C and D: Serum lipids, TyG index, and AI in patients with right-sided CRC (RCSS) and left-sided CRC (LCSS). Data are presented as the mean ± standard deviation and analyzed by the Student’s t-test. aP < 0.05; bP < 0.01; cP < 0.001. HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; TC: Total cholesterol; TG: Triglyceride.

• 

  Figure 6. Serum lipid levels in patients with colorectal cancer with normal carcinoembryonic antigen and carbohydrate antigen 19-9. A and B: Serum lipids, triglyceride-glucose (TyG) index, and atherosclerotic index (AI) in patients with colorectal cancer (CRC) with normal carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 before propensity score matching (PSM); C and D: Serum lipids, TyG index, and AI in patients with CRC with normal CEA and CA19-9 after PSM. Data are presented as the mean ± standard deviation and analyzed by the Student’s t-test. aP < 0.05; bP < 0.01; cP < 0.001. HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; TC: Total cholesterol; TG: Triglyceride.

• 

  Figure 7. Various combined diagnostic indicators for patients with colorectal cancer. AI: Atherosclerotic index; AUC: Area under the curve; CEA: Carcinoembryonic antigen; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; TC: Total cholesterol; TG: Triglyceride; TyG: Triglyceride-glucose.

• 

  Figure 8. Nomogram for colorectal cancer diagnosis. AUC: Area under the curve; CEA: Carcinoembryonic antigen; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; TC: Total cholesterol; TG: Triglyceride; TyG: Triglyceride-glucose.